Ocular manifestations of systemic lupus erythematosus

被引:138
作者
Sivaraj, R. R.
Durrani, O. M.
Denniston, A. K.
Murray, P. I.
Gordon, Caroline
机构
[1] Univ Birmingham, Sch Med, Div Immun & Infect, Dept Rheumatol,Rheumatol E Wing, Birmingham B18 7QU, W Midlands, England
[2] Univ Birmingham, Acad Unit Ophthalmol, Birmingham B18 7QU, W Midlands, England
基金
英国医学研究理事会;
关键词
lupus; ocular; ophthalmic; retinal; scleral; corneal; optic;
D O I
10.1093/rheumatology/kem173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ocular manifestations of lupus are fairly common, may be the presenting feature of the disease and can be sight-threatening. Almost any part of the eye and visual pathway can be affected by inflammatory or thrombotic processes. Ocular pain and visual impairment require urgent assessment by an ophthalmologist. Infection should be excluded. Optic neuritis and ischaemic optic neuropathy may be difficult to distinguish. Scleritis and severe retinopathy require systemic immunosuppression but episcleritis, anterior uveitis and dry eyes can usually be managed with local eye drops. Vaso-occlusive disease, particularly in the presence of antiphospholipid antibodies, requires treatment with anticoagulation and proliferative retinopathy is treated with laser therapy. Hydroxychloroquine rarely causes ocular toxicity at doses under 6.5mg/kg/day. When this has occurred, it has been associated with more than 5 years of drug exposure.
引用
收藏
页码:1757 / 1762
页数:6
相关论文
共 52 条
[31]  
JABS DA, 1986, ARCH OPHTHALMOL-CHIC, V104, P564
[32]  
JACKSON G, 1986, J RHEUMATOL, V13, P1161
[33]  
Jensen JL, 1999, J ORAL PATHOL MED, V28, P317
[34]   ORBITAL PANNICULITIS AS THE INITIAL MANIFESTATION OF SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
JORDAN, DR ;
MCDONALD, H ;
OLBERG, B ;
MCKIM, D ;
MCKENDRY, R .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 1993, 9 (01) :71-75
[35]   OCULAR IMMUNE REACTANTS IN PATIENTS DYING WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
KARPIK, AG ;
SCHWARTZ, MM ;
DICKEY, LE ;
STREETEN, BW ;
ROBERTS, JL .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1985, 35 (03) :295-312
[36]   EYE-MOVEMENT ABNORMALITIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
KEANE, JR .
ARCHIVES OF NEUROLOGY, 1995, 52 (12) :1145-1149
[37]   Lupus choroidopathy and choroidal effusions [J].
Laviña, AM ;
Agarwal, A ;
Hunyor, A ;
Gass, JDM .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2002, 22 (05) :643-647
[38]   Hydroxychloroquine screening [J].
Lee, AG .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2005, 89 (05) :521-522
[39]   Recommendations on screening for chloroquine and hydroxychloroquine retinopathy - A report by the American Academy of Ophthalmology [J].
Marmor, MF ;
Carr, RE ;
Easterbrook, M ;
Farjo, AA ;
Mieler, WF .
OPHTHALMOLOGY, 2002, 109 (07) :1377-1382
[40]   The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine - A reappraisal [J].
Mavrikakis, I ;
Sfikakis, PP ;
Mavrikakis, E ;
Rougas, K ;
Nikolaou, A ;
Kostopoulos, C ;
Mavrikakis, M .
OPHTHALMOLOGY, 2003, 110 (07) :1321-1326